Manage episode 236874596 series 1947483
Last November we discussed the updated lipid guidelines. We wanted to revisit the treatment options for dyslipidemia and discuss some of the updated data that has been recently released. We review pathophysiology, as well as statin and non-statin therapy options. We walk through the algorithms for secondary prevention for patients with ASCVD, treatment for hypercholesterolemia, primary prevention, and statin use in patients with diabetes. We also review the recently published REDUCE IT trial from the New England Journal of Medicine.
Below is the link for the ASCVD Risk Plus calculator:
Below is the link to the summary written by Wiki Journal Club for the REDUCE IT trial:
If you have any questions, reach out to us on any of the following:
Mike - email@example.com Cole - firstname.lastname@example.org
Instagram and other social media platforms - @corconsultrx
This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.